Inspire Medical Systems (INSP)

Sell: $58.60|Buy: $62.00|Change: 0.11 (0.18%)

Company profile

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Address

5500 Wayzata Boulevard
Suite 1600
Golden Valley
MN
USA
55416


Telephone

+1 646 5976989


Sector 

Healthcare


Previous key dates

NameKey Date
Inspire Medical Systems Inc Annual Report for 20252026-02-18T00:00:00
Inspire Medical Systems Inc Fourth Quarter Earnings Conference Call for 20252026-02-11T17:00:00
Inspire Medical Systems Inc Fourth Quarter Earnings Results for 20252026-02-11T00:00:00
44(th) Annual J.P. Morgan Healthcare Conference2026-01-12T12:45:00
Piper Sandler 37(th) Annual Healthcare Conference2025-12-02T11:30:00
2025 UBS Global Healthcare Conference2025-11-10T11:45:00
Inspire Medical Systems Inc Third Quarter Earnings Conference Call for 20252025-11-03T17:00:00
Inspire Medical Systems Inc Third Quarter Earnings Result for 20252025-11-03T00:00:00
Wells Fargo 2025 Healthcare Conference2025-09-03T11:00:00
Inspire Medical Systems Inc Second Quarter Earnings Conference Call for 20252025-08-04T17:00:00
Inspire Medical Systems Inc Second Quarter Earnings Results for 20252025-08-04T00:00:00
2025 MedTech Innovation Spotlight | Inspire Medical Systems Inc2025-06-13T12:00:00
Inspire Medical Systems Inc First Quarter Earnings Conference Call for 20252025-05-05T17:00:00
Inspire Medical Systems Inc First Quarter Earnings Results for 20252025-05-05T00:00:00
Inspire Medical Systems Inc Annual General Meeting for 20252025-05-01T09:00:00
KeyBanc Capital Markets Healthcare Forum2025-03-18T15:00:00
Inspire Medical Systems Inc Fourth Quarter Earnings Conference Call for 20242025-02-10T17:00:00
Inspire Medical Systems Inc Fourth Quarter Earnings Result for 20242025-02-10T00:00:00
Inspire Medical Systems Inc Annual Report for 20242025-02-10T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.